HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chang-Ho Ahn Selected Research

RX 0047

1/2016Lipid-Albumin Nanoparticles (LAN) for Therapeutic Delivery of Antisense Oligonucleotide against HIF-1α.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chang-Ho Ahn Research Topics

Disease

8Neoplasms (Cancer)
01/2016 - 11/2009
2Colorectal Neoplasms (Colorectal Cancer)
11/2010 - 09/2010
1Kidney Neoplasms (Kidney Cancer)
06/2018
1Hypoxia (Hypoxemia)
01/2016
1Parkinson Disease (Parkinson's Disease)
08/2012
1Major Depressive Disorder (Major Depressive Disorders)
10/2011
1Pancreatic Neoplasms (Pancreatic Cancer)
11/2009

Drug/Important Bio-Agent (IBA)

3Antisense OligonucleotidesIBA
06/2018 - 11/2009
3GemcitabineFDA Link
12/2014 - 11/2010
3Pharmaceutical PreparationsIBA
11/2010 - 11/2009
2PiperazineIBA
08/2015 - 11/2010
2CytidineIBA
12/2014 - 12/2013
2fluorocyclopentenylcytosineIBA
12/2014 - 12/2013
2Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric
08/2012 - 10/2011
2Paclitaxel (Taxol)FDA LinkGeneric
11/2010 - 09/2010
1RX-0201IBA
06/2018
1AlbuminsIBA
01/2016
1RX 0047IBA
01/2016
1LipidsIBA
01/2016
1CateninsIBA
08/2015
1RX-5902IBA
08/2015
1Cyclin D1IBA
08/2015
1RNA Helicases (RNA Helicase)IBA
08/2015
1NeurotoxinsIBA
08/2012
11-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA
08/2012
1QuinoxalinesIBA
02/2012
1Fluorouracil (Carac)FDA LinkGeneric
11/2010
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2010
1Cisplatin (Platino)FDA LinkGeneric
11/2010
1Antineoplastic Agents (Antineoplastics)IBA
11/2010
1LuciferasesIBA
11/2009
1Proteins (Proteins, Gene)FDA Link
11/2009
1Messenger RNA (mRNA)IBA
11/2009

Therapy/Procedure

1Therapeutics
11/2010